Lazzari, G. (2025) “The Impact of KEYNOTE-522 Related Immune-Related Adverse Events on Concurrent Adjuvant Whole Breast Radiotherapy in the Real World: A Case Series: KEYNOTE-522 and adjuvant hypofractionated RT”, Archives of Breast Cancer, 12(2), pp. 231–235. doi: 10.32768/abc.2025122231-235.